Cas 1609929-53-4,1-acetyl-N-cyclohexyl-7-methyl-3-phenyl-1,4-dihydroquinoxaline-2-carboxamide

1609929-53-4

Post Buying Request

Basic information

Product Name: 1-acetyl-N-cyclohexyl-7-methyl-3-phenyl-1,4-dihydroquinoxaline-2-carboxamide
Synonyms: 1-acetyl-N-cyclohexyl-7-methyl-3-phenyl-1,4-dihydroquinoxaline-2-carboxamide
CAS NO:1609929-53-4
Molecular Formula:
Molecular Weight: 389.497
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1-acetyl-N-cyclohexyl-7-methyl-3-phenyl-1,4-dihydroquinoxaline-2-carboxamide(CAS DataBase Reference)
NIST Chemistry Reference: 1-acetyl-N-cyclohexyl-7-methyl-3-phenyl-1,4-dihydroquinoxaline-2-carboxamide(1609929-53-4)
EPA Substance Registry System: 1-acetyl-N-cyclohexyl-7-methyl-3-phenyl-1,4-dihydroquinoxaline-2-carboxamide(1609929-53-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1609929-53-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1609929-53-4 Suppliers

Recommended suppliers

1609929-53-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1609929-53-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,0,9,9,2 and 9 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1609929-53:
(9*1)+(8*6)+(7*0)+(6*9)+(5*9)+(4*2)+(3*9)+(2*5)+(1*3)=204
204 % 10 = 4
So 1609929-53-4 is a valid CAS Registry Number.

1609929-53-4Upstream product

1609929-53-4Downstream Products

1609929-53-4Relevant academic research and scientific papers

Ugi-based approaches to quinoxaline libraries

Azuaje, Jhonny,El Maatougui, Abdelaziz,Garcia-Mera, Xerardo,Sotelo, Eddy

supporting information, p. 403 - 411 (2014/09/17)

An expedient and concise Ugi-based unified approach for the rapid assembly of quinoxaline frameworks has been developed. This convergent and versatile method uses readily available commercial reagents, does not require advanced intermediates, and exhibits

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1609929-53-4